Multicenter Randomized Controlled Trial on the Interest of Intravitreal Injections of Anti-VEGF as Initial and Adjuvant Treatment in Coats Disease

Conditions:   Retinal Telangiectasis;   Coats Disease Interventions:   Drug: Anti-VEGF injections of bevacizumab;   Device: Laser Sponsor:   Fondation Ophtalmologique Adolphe de Rothschild Not yet recruiting

Source: ClinicalTrials.gov - May 7, 2019 Category: Research Source Type: clinical trials